Open AccessAdjuvant Therapy for Esophageal Squamous Cell Carcinoma
Author(s) -
JongMu Sun
Publication year - 2020
Publication title -
the korean journal of thoracic and cardiovascular surgery/daehan hyungbu oe'gwa haghoeji. hyungbu simjang hyeolgwan
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2093-6516
pISSN - 0301-2859
DOI - 10.5090/kjtcs.2020.53.4.168
Subject(s) - medicine , adjuvant , adjuvant therapy , esophageal cancer , esophageal squamous cell carcinoma , oncology , immunotherapy , basal cell , carcinoma , neoadjuvant therapy , surgery , cancer , breast cancer
Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise review of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy.